跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,770 条关于
“B7-H3 antibody”
全部
12,770
临床试验
4,835
药物
2,175
机构
55
资讯
5,705
去年
HS-20093 (GSK'227) Receives FDA and EMA Designations for Osteosarcoma and SCLC
去年
GSK's GSK'227 Receives FDA Breakthrough Therapy Designation for Relapsed Osteosarcoma
2年前
GSK's GSK5764227 Receives FDA Breakthrough Therapy Designation for Extensive-Stage Small Cell Lung Cancer
9个月前
FDA Grants Orphan Drug Designation to GSK's B7-H3-Targeted ADC for Small-Cell Lung Cancer
2年前
GSK Licenses Hansoh Pharma's B7-H3 ADC, HS-20093, for $185 Million Upfront
5个月前
Palleon Pharmaceuticals to Present First-in-Class B7-H3-Targeted Sialidase HLX316/E-688 at AACR 2026
去年
GSK's B7-H3-Targeted ADC, GSK'227, Receives FDA Breakthrough Therapy Designation for Osteosarcoma
5天前
Ris-Rez Cuts Death Risk 54% Versus Topotecan in Relapsed SCLC, First Phase III OS Win for a B7-H3 ADC
11个月前
Mabwell's B7-H3-Targeting ADC 7MW3711 Shows Promising Efficacy in Advanced Solid Tumors
2年前
Phase 3 Trial of Ifinatamab Deruxtecan Launched for Relapsed Small Cell Lung Cancer
第 1 页,共 571 页
上一页
下一页